BRIEF published on 06/12/2025 at 11:05, 1 year 4 months ago Relief Therapeutics Announces Results of Annual General Meeting Financial Statements Shareholder Approval Annual Meeting Board Elections Compensation Approval
PRESS RELEASE published on 06/12/2025 at 11:00, 1 year 4 months ago Relief Therapeutics Announces Results of Annual General Meeting Relief Therapeutics announces results of its Annual General Meeting with shareholders approving all proposals by a large majority. AGM covers key agenda items and re-election of board members and auditors Board Of Directors Annual General Meeting Shareholders Relief Therapeutics AGM Results
BRIEF published on 05/22/2025 at 07:05, 1 year 5 months ago Relief Therapeutics Secures FDA Rare Pediatric Disease Designation for RLF-TD011 FDA Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Rare Pediatric Disease
PRESS RELEASE published on 05/22/2025 at 07:00, 1 year 5 months ago Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 Relief Therapeutics granted FDA Rare Pediatric Disease Designation for RLF-TD011 in treating epidermolysis bullosa, a rare genetic skin disorder. Potent antimicrobial & anti-inflammatory activity shown FDA Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Rare Pediatric Disease Designation
BRIEF published on 05/15/2025 at 07:05, 1 year 5 months ago Relief Therapeutics Announces 2025 AGM Agenda Annual General Meeting Financial Statements Shareholder Voting Board Re-election Compensation Approval
PRESS RELEASE published on 05/15/2025 at 07:00, 1 year 5 months ago Relief Therapeutics Publishes 2025 Annual General Meeting Agenda Relief Therapeutics announces agenda for its 2025 Annual General Meeting featuring key resolutions and re-elections. Meeting scheduled for June 12 in Geneva, Switzerland Shareholders Switzerland Relief Therapeutics Agenda 2025 Annual General Meeting
BRIEF published on 04/10/2025 at 07:05, 1 year 6 months ago Relief Therapeutics Announces 2024 Financial Results and Strategic Progress Biopharmaceutical Relief Therapeutics Rare Diseases 2024 Financial Results Pipeline Progress
PRESS RELEASE published on 04/10/2025 at 07:00, 1 year 6 months ago Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update Relief Therapeutics reports 2024 financial results and provides a corporate update, emphasizing operational achievements, pipeline momentum, and strengthened financial position Biopharmaceutical Corporate Update Relief Therapeutics Rare Diseases 2024 Financial Results
BRIEF published on 03/06/2025 at 07:05, 1 year 7 months ago Relief Therapeutics Ends Merger Discussions with Renexxion Shareholder Value Relief Therapeutics Strategic Objectives Renexxion Merger Termination
PRESS RELEASE published on 03/06/2025 at 07:00, 1 year 7 months ago Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion Relief Therapeutics terminates merger discussions with Renexxion after failing to meet key conditions. Company remains well-positioned with robust pipeline and cash reserves Relief Therapeutics Cash Reserves Therapeutic Pipeline Renexxion Merger Discussions
Published on 11/04/2026 at 00:05, 8 hours 52 minutes ago Scoping Study Begins for High-Grade Underground Mine Feed
Published on 11/04/2026 at 00:00, 8 hours 57 minutes ago RE Royalties Launches $5 Million Series 5 Green Bond Offering and Provides Strategic Growth Update
Published on 11/03/2026 at 23:30, 9 hours 27 minutes ago AT&T and Amdocs Expand Collaboration, Bringing Together Amdocs aOS and AT&T's AI-Enabled Framework to Simplify Operations and Improve Customer Experiences
Published on 11/03/2026 at 23:30, 9 hours 27 minutes ago GGL Resources Corp. Issues Post-Consolidation Shares to Strategic Metals Ltd.
Published on 11/04/2026 at 08:37, 19 minutes ago Blue Elephant Energy takes over substation from Bayernwerk Netz – State Secretary Tobias Gotthardt visits the Schafhöfen solar park
Published on 11/04/2026 at 08:05, 52 minutes ago Corero Network Security Accelerates International Growth with Strategic Investment in Regional Leadership and Partnerships
Published on 11/04/2026 at 08:05, 52 minutes ago KFC Brings the Doom: New Marvel-Inspired Menu Lands Ahead of Marvel Studios' "Avengers: Doomsday"
Published on 11/04/2026 at 08:00, 57 minutes ago Key data for the 18th capital increase of the Akara Swiss Diversity Property Fund PK (Akara Fund)
Published on 11/04/2026 at 08:00, 57 minutes ago Metro Bank Holdings PLC: Third Quarter 2026 Trading Update
Published on 11/03/2026 at 18:00, 14 hours 57 minutes ago Outstanding Shares and Voting Rights Monthly Statement - 31 October 2026
Published on 11/03/2026 at 17:45, 15 hours 12 minutes ago Declaration of voting rights at the end of October 2026
Published on 11/02/2026 at 18:30, 1 day 14 hours ago Disclosure of transactions in own shares from October 26 to October 30, 2026
